MESO
Mesoblast (MESO)
$84
About Mesoblast (MESO)
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Details
Daily high
$15.86
Daily low
$15.71
Price at open
$15.78
52 Week High
$21.50
52 Week Low
$12.66
Market cap
2.0B
Dividend yield
0.00%
Volume
34,144
Avg. volume
275,761
P/E ratio
-21.18
Mesoblast News
Details
Daily high
$15.86
Daily low
$15.71
Price at open
$15.78
52 Week High
$21.50
52 Week Low
$12.66
Market cap
2.0B
Dividend yield
0.00%
Volume
34,144
Avg. volume
275,761
P/E ratio
-21.18